Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer. | J Exp Clin Cancer Res | 2025 | 40847369 | PubTator, text mining | PubMed |
| Identification of Plasma Biomarkers for B7 Family Members Associated With Primary Sjögren's Syndrome. | Immun Inflamm Dis | 2025 | 40844039 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Multi-Omics analysis and in vitro validation reveal diagnostic and therapeutic roles of novel hub genes in ovarian cancer. | Hereditas | 2025 | 40826138 | PubTator, text mining | PubMed |
| PTK6 mediated immune signatures revealed by single cell transcriptomic and multi omics big data analysis in cervical cancer. | Discov Oncol | 2025 | 40818002 | PubTator, text mining | PubMed |
| ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma. | Clin Cancer Res | 2025 | 40788182 | PubTator, text mining | PubMed |
| Patient-derived ovarian cancer models demonstrate the influence of tumor-associated macrophages on therapeutic response. | Oncoimmunology | 2025 | 40747680 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Investigation of the Effects of B7H4 (rs10754339 A>G) Gene Polymorphism and Serum Level on Breast Cancer Susceptibility. | Asian Pac J Cancer Prev | 2025 | 40729077 | PubTator, text mining | PubMed |
| Applications and techniques of single-cell RNA sequencing across diverse species. | Brief Bioinform | 2025 | 40698863 | PubTator, text mining | PubMed |
| VTCN1 emerges as a biomarker of immune tolerance in osimertinib-resistant lung cancer. | Anticancer Drugs | 2025 | 40674089 | PubTator, text mining | PubMed |
| Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER- breast cancer. | JCI Insight | 2025 | 40663402 | PubTator, text mining | PubMed |
| Identification of Key Genes for Alcoholic Hepatitis Using Integrated Network Analysis of Differential lncRNA and Gene Expression. | Int J Mol Sci | 2025 | 40649881 | PubTator, text mining | PubMed |
| Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment. | NPJ Precis Oncol | 2025 | 40603576 | PubTator, text mining | PubMed |
| Spatial Transcriptome Analysis of B7-H4 in Head and Neck Squamous Cell Carcinoma: A Novel Therapeutic Target for Anti-Immune Checkpoint Inhibitors. | Head Neck Pathol | 2025 | 40586978 | PubTator, text mining | PubMed |
| A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer. | Nat Commun | 2025 | 40506428 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles for Tumor-Targeted Delivery of Therapeutic siRNA for Lung Cancer Therapy. | ACS Biomater Sci Eng | 2025 | 40493869 | PubTator, text mining | PubMed |
| The tumor microenvironment of non-small cell lung cancer impairs immune cell function in people with HIV. | J Clin Invest | 2025 | 40459946 | PubTator, text mining | PubMed |
| SK4 potentially modulates the alternative splicing profile associated with papillary thyroid cancer development in BHT101 cells. | PeerJ | 2025 | 40452939 | PubTator, text mining | PubMed |
| Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer. | Eur J Cancer | 2025 | 40446758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=6